johnson & johnson news

Johnson & Johnson Gets FDA Priority Review of Nipocalimab

J&J gets Priority Review designation for nipocalimab BLA

Johnson & Johnson (NYSE:JNJ) has received Priority Review designation from the FDA for the Biologics License Application for its drug nipocalimab in the treatment of antibody-positive patients with generalized myasthenia gravis.

Business Insider · 18h

Johnson & Johnson reports nipocalimab granted FDA Priority Review

Johnson & Johnson announced the nipocalimab Biologics License Application received Priority Review designation from the U.S Food and Drug

MarketWatch · 18h

Johnson & Johnson Gets FDA Priority Review of Nipocalimab in Generalized Myasthenia Gravis

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

Don’t rule out Ben Johnson returning to Lions

AtoZ Sports on MSN · 16h

NFL sources are very split on what Lions' offensive coordinator Ben Johnson will do with his future

At this point it feels like an annual edge of your seat anxiety attack, doesn't it? For the third year in a row, everyone is wondering what Detroit Lions offensive coordinator Ben Johnson is going to do.

Bleacher Report · 17h

NFL Rumors: Insiders Feel Ben Johnson May Stay with Lions; HC Talk Isn't 'Leverage'

Detroit Lions offensive coordinator Ben Johnson is one of the most coveted coaching candidates on the market for the third straight year, but he

ClutchPoints on MSN · 17h

NFL rumors: Don’t rule out Ben Johnson returning to Lions

Detroit Lions offensive coordinator Ben Johnson turned down head coaching opportunities last offseason, and while many expect him to take a job this offseason, it remains a possibility that he could stay in Detroit under Dan Campbell once again,

Trump's Panama Canal Demand Gets Boost From New House Bill

FOX News on MSN · 12h

House Republicans introduce bill to repurchase Panama Canal after Trump raises concerns of Chinese control

S.D., introduced the Panama Canal Repurchase Act, co-sponsored by 15 other House Republicans, amid President-elect Trump's concerns.

Newsweek on MSN · 1d

Donald Trump's Panama Canal Demand Gets Boost From New House Bill

South Dakota Republican Rep. Dusty Johnson's new bill is expected to aid Trump's goal of returning the Panama Canal to the U.S.

Yahoo · 6h

SD Rep. Dusty Johnson introduces bill to reacquire Panama Canal

Just days after the idea of again taking control of the Panama Canal was pushed by president-elect Donald Trump, South Dakota representative Dusty Johnson has introduced a bill that would do just that.

Mike Vrabel has a real advantage over Ben Johnson

Yahoo! Sports · 1d

Why Mike Vrabel has a real advantage over Ben Johnson in Pats HC search

Phil Perry and Underdog Fantasy's James Palmer discuss the biggest differences between Patriots head coaching candidates Mike Vrabel and Ben Johnson.

The New York Times · 1d

Mike Vrabel or Ben Johnson? What we’re hearing about the Patriots’ coaching search

The latest on New England's coaching search has Vrabel interviewing Thursday and Johnson and Aaron Glenn following suit virtually.

ClutchPoints on MSN · 17h

NFL rumors: Why Ben Johnson can’t be ruled out for Patriots amid Mike Vrabel pursuit

The New England Patriots are in the market for a head coach again this offseason, as they fired Jerod Mayo after just one year with the team. Former Tennessee Titans head coach Mike Vrabel has immediately emerged as the frontrunner to land this gig,

18h

Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

GlobalData on MSN20h

Johnson & Johnson MedTech pauses Varipulse rollout in US

Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.

Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Hold Recommendation for Johnson & Johnson Amid Promising Drug Trials and Regulatory Challenges

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) and keeping the price ...

15h

Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events

Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA therapy and 3D mapping for AFib treatment.

STAT2d

Johnson & Johnson says its lung cancer drug significantly extended survival

Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

Johnson & Johnson price target lowered to $160 from $177 at Bernstein

Bernstein lowered the firm’s price target on Johnson & Johnson to $160 from $177 and keeps a Market Perform rating on the shares as part of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Johnson & Johnson Gets FDA Priority Review of Nipocalimab

Don’t rule out Ben Johnson returning to Lions

Trump's Panama Canal Demand Gets Boost From New House Bill

Mike Vrabel has a real advantage over Ben Johnson

Related topics